Delivery Order SPE2DB22D3010-SPE2DB26FP0UC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,355.26 under a firm fixed-price contract. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $9,053.16 and a firm fixed price structure. This non-set-aside competitive award is set to conclude on December 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,106.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ofev 150 mg capsules in quantities of 60 units. The contract is scheduled for completion by January 2, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,630.28, with completion scheduled for August 27, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award involved...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 10, 2025, and performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 with a firm fixed price contract type. The award is non-set-aside and represents a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ofev 150 mg capsules (60-count packaging) with a ceiling value of $9,053.16. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units). This firm fixed-price contract, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive, open-market procurement. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed price contract with a ceiling value of $9,053.16. This non-set-aside competitive award is scheduled for completion by December 22, 2025, with performance taking place at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0UCDelivery Order
The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ofev 150 mg capsules (60-count units). This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical commodity will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 20, 2025. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. This delivery order for Ofev, a pulmonary fibrosis treatment, exemplifies the breadth of pharmaceutical products the contractor provides through its expansive federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 10/29/25 |